{"entity":{"type":"insider","cik":"0001646976","url":"/insider/0001646976","json_url":"/insider/0001646976.json","name":"Adda Nathalie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":13,"first":"2018-04-18","last":"2022-04-05","span_basis":"filed_date"},"name_variants":[{"name":"Adda Nathalie","source":"filing","n_filings":13,"first_seen":"2018-04-18","last_seen":"2022-04-05"}],"transactions":[{"id":6365609,"accession":"0001062993-22-009836","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001062993-22-009836","line_url":"/filing/0001062993-22-009836","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32785.0,"shares_display":"32,785","price_per_share":72.18394814701846,"price_display":"72.18","price_state":"stated","total_value":2366550.74,"total_display":"2,366,550.74","total_whole":"2,366,551","shares_owned_after":47191.0,"shares_owned_after_display":"47,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider","n_lines":4},{"id":6365602,"accession":"0001062993-22-009836","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-009836","line_url":"/filing/0001062993-22-009836","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50559.0,"shares_display":"50,559","price_per_share":71.22643742953777,"price_display":"71.23","price_state":"stated","total_value":3601137.45,"total_display":"3,601,137.45","total_whole":"3,601,137","shares_owned_after":34982.0,"shares_owned_after_display":"34,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider","n_lines":2},{"id":6321510,"accession":"0001062993-22-006708","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-006708","line_url":"/filing/0001062993-22-006708#line-5","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12481.0,"shares_display":"12,481","price_per_share":70.07,"price_display":"70.07","price_state":"stated","total_value":874543.67,"total_display":"874,543.67","total_whole":"874,544","shares_owned_after":34982.0,"shares_owned_after_display":"34,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider"},{"id":6321506,"accession":"0001062993-22-006708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-006708","line_url":"/filing/0001062993-22-006708","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24339.0,"shares_display":"24,339","price_per_share":70.26328690578906,"price_display":"70.26","price_state":"stated","total_value":1710138.14,"total_display":"1,710,138.14","total_whole":"1,710,138","shares_owned_after":35082.0,"shares_owned_after_display":"35,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider","n_lines":2},{"id":6365440,"accession":"0001062993-22-001041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-001041","line_url":"/filing/0001062993-22-001041#line-3","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12536.0,"shares_display":"12,536","price_per_share":70.13,"price_display":"70.13","price_state":"stated","total_value":879149.68,"total_display":"879,149.68","total_whole":"879,150","shares_owned_after":32902.0,"shares_owned_after_display":"32,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider"},{"id":4582753,"accession":"0001062993-21-012213","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001062993-21-012213","line_url":"/filing/0001062993-21-012213","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13523.0,"shares_display":"13,523","price_per_share":86.34843969533388,"price_display":"86.35","price_state":"stated","total_value":1167689.95,"total_display":"1,167,689.95","total_whole":"1,167,690","shares_owned_after":39102.0,"shares_owned_after_display":"39,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider","n_lines":7},{"id":4595030,"accession":"0001177648-21-000029","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001177648-21-000029","line_url":"/filing/0001177648-21-000029","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9547.0,"shares_display":"9,547","price_per_share":84.88729653294229,"price_display":"84.89","price_state":"stated","total_value":810419.02,"total_display":"810,419.02","total_whole":"810,419","shares_owned_after":27044.0,"shares_owned_after_display":"27,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-02","scope":"insider","n_lines":3},{"id":4890631,"accession":"0001177648-21-000027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001177648-21-000027","line_url":"/filing/0001177648-21-000027#line-4","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4047.0,"shares_display":"4,047","price_per_share":70.3448,"price_display":"70.34","price_state":"stated","total_value":284685.4056,"total_display":"284,685.41","total_whole":"284,685","shares_owned_after":26944.0,"shares_owned_after_display":"26,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-13","scope":"insider"},{"id":4890622,"accession":"0001177648-21-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001177648-21-000027","line_url":"/filing/0001177648-21-000027#line-2","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13453.0,"shares_display":"13,453","price_per_share":70.091,"price_display":"70.09","price_state":"stated","total_value":942934.223,"total_display":"942,934.22","total_whole":"942,934","shares_owned_after":26944.0,"shares_owned_after_display":"26,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-13","scope":"insider"},{"id":6629014,"accession":"0001177648-18-000035","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001177648-18-000035","line_url":"/filing/0001177648-18-000035","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4155.0,"shares_display":"4,155","price_per_share":95.31554912154031,"price_display":"95.32","price_state":"stated","total_value":396036.1066,"total_display":"396,036.11","total_whole":"396,036","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-20","filed_date":"2018-09-21","scope":"insider","n_lines":5},{"id":6311927,"accession":"0001177648-18-000033","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001177648-18-000033","line_url":"/filing/0001177648-18-000033","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4155.0,"shares_display":"4,155","price_per_share":92.32157898916968,"price_display":"92.32","price_state":"stated","total_value":383596.1607,"total_display":"383,596.16","total_whole":"383,596","shares_owned_after":969.0,"shares_owned_after_display":"969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-21","scope":"insider","n_lines":4},{"id":9238279,"accession":"0001177648-18-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001177648-18-000034","line_url":"/filing/0001177648-18-000034","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4155.0,"shares_display":"4,155","price_per_share":125.08685333333334,"price_display":"125.09","price_state":"stated","total_value":519735.8756,"total_display":"519,735.88","total_whole":"519,736","shares_owned_after":4925.0,"shares_owned_after_display":"4,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-18","filed_date":"2018-09-21","scope":"insider","n_lines":4},{"id":6512519,"accession":"0001177648-18-000031","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001177648-18-000031","line_url":"/filing/0001177648-18-000031","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5045.0,"shares_display":"5,045","price_per_share":124.84492975222993,"price_display":"124.84","price_state":"stated","total_value":629842.6706,"total_display":"629,842.67","total_whole":"629,843","shares_owned_after":4480.0,"shares_owned_after_display":"4,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-18","filed_date":"2018-07-19","scope":"insider","n_lines":4},{"id":5985402,"accession":"0001177648-18-000028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001177648-18-000028","line_url":"/filing/0001177648-18-000028","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4155.0,"shares_display":"4,155","price_per_share":114.85492122743682,"price_display":"114.85","price_state":"stated","total_value":477222.1977,"total_display":"477,222.20","total_whole":"477,222","shares_owned_after":4258.0,"shares_owned_after_display":"4,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-18","filed_date":"2018-06-19","scope":"insider","n_lines":3},{"id":6036990,"accession":"0001177648-18-000024","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001177648-18-000024","line_url":"/filing/0001177648-18-000024","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4155.0,"shares_display":"4,155","price_per_share":105.25466089049338,"price_display":"105.25","price_state":"stated","total_value":437333.116,"total_display":"437,333.12","total_whole":"437,333","shares_owned_after":4800.0,"shares_owned_after_display":"4,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-18","scope":"insider","n_lines":3},{"id":6347945,"accession":"0001177648-18-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001177648-18-000022","line_url":"/filing/0001177648-18-000022","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001646976","owner_name":"Adda Nathalie","owner_display_name":"Adda Nathalie","owner_url":"/insider/0001646976","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4225.0,"shares_display":"4,225","price_per_share":85.57625621301776,"price_display":"85.58","price_state":"stated","total_value":361559.6825,"total_display":"361,559.68","total_whole":"361,560","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-16","filed_date":"2018-04-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001177648","name":"ENANTA PHARMACEUTICALS INC","url":"/issuer/0001177648","role":"Officer (Sr. VP & Chief Medical Officer)","n_filings":13,"first_seen":"2018-04-18","last_seen":"2022-04-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001646976","retrieved_at":"2026-08-27T13:23:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}